Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.

Starnes SL, Pathrose P, Wang J, Succop P, Morris JC, Bridges J, Kupert EY, Anderson M.

Ann Thorac Surg. 2012 May;93(5):1606-12. doi: 10.1016/j.athoracsur.2012.01.048. Epub 2012 Mar 20.

PMID:
22440368
2.

Arterial invasion predicts early mortality in stage I non-small cell lung cancer.

Pechet TT, Carr SR, Collins JE, Cohn HE, Farber JL.

Ann Thorac Surg. 2004 Nov;78(5):1748-53. Review.

PMID:
15511466
3.

A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.

Xu YH, Lu S.

Eur J Surg Oncol. 2014 Mar;40(3):311-7. doi: 10.1016/j.ejso.2013.11.012. Epub 2013 Dec 4. Review.

PMID:
24332948
4.

Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.

Deng XF, Liu QX, Zhou D, Min JX, Dai JG.

Interact Cardiovasc Thorac Surg. 2015 Jul;21(1):21-7. doi: 10.1093/icvts/ivv082. Epub 2015 Apr 15. Review.

5.

Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer.

Huang H, Wang T, Hu B, Pan C.

Ann Thorac Surg. 2015 Apr;99(4):1130-9. doi: 10.1016/j.athoracsur.2014.11.052. Epub 2015 Feb 20. Review.

PMID:
25704861
6.

Prediction of recurrence after complete resection in patients with NSCLC.

Uramoto H, Tanaka F.

Anticancer Res. 2012 Sep;32(9):3953-60. Review.

PMID:
22993343
7.

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

Wang J, Chen J, Chen X, Wang B, Li K, Bi J.

PLoS One. 2011;6(12):e28844. doi: 10.1371/journal.pone.0028844. Epub 2011 Dec 14. Review.

8.

A meta-analysis of resected metachronous second non-small cell lung cancer.

Hamaji M, Ali SO, Burt BM.

Ann Thorac Surg. 2015 Apr;99(4):1470-8. doi: 10.1016/j.athoracsur.2014.11.033. Epub 2015 Feb 26. Review.

PMID:
25725930
9.

The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis.

Zhang LQ, Jiang F, Xu L, Wang J, Bai JL, Yin R, Wu YQ, Meng LJ.

Clin Lung Cancer. 2012 May;13(3):188-95. doi: 10.1016/j.cllc.2011.10.003. Epub 2011 Dec 1. Review.

PMID:
22133292
10.

High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer.

Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, Liao Y, Du J.

Eur J Cancer. 2013 Feb;49(3):604-15. doi: 10.1016/j.ejca.2012.09.031. Epub 2012 Oct 22. Review.

PMID:
23099007
11.

Molecular and biological factors in the prognosis of non-small cell lung cancer.

Kanters SD, Lammers JW, Voest EE.

Eur Respir J. 1995 Aug;8(8):1389-97. Review.

12.

The emerging role of circulating tumor cells in breast cancer.

Krishnamurthy S.

Cancer Cytopathol. 2012 Jun 25;120(3):161-6. doi: 10.1002/cncy.20207. Epub 2012 Jan 24. Review. No abstract available.

13.

Postoperative surveillance for non-small cell lung cancer resected with curative intent: developing a patient-centered approach.

Mollberg NM, Ferguson MK.

Ann Thorac Surg. 2013 Mar;95(3):1112-21. doi: 10.1016/j.athoracsur.2012.09.075. Epub 2013 Jan 23. Review.

PMID:
23352418
14.

Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer.

Wang T, Luo L, Huang H, Yu J, Pan C, Cai X, Hu B, Yin X.

Ann Thorac Surg. 2014 May;97(5):1827-37. doi: 10.1016/j.athoracsur.2013.12.044. Epub 2014 Mar 25. Review.

PMID:
24674755
15.

Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer?

Churchhouse AM, Mathews TJ, McBride OM, Dunning J.

Interact Cardiovasc Thorac Surg. 2012 Jan;14(1):85-90. doi: 10.1093/icvts/ivr025. Epub 2011 Nov 15. Review.

16.

Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes.

Fedor D, Johnson WR, Singhal S.

Surg Oncol. 2013 Sep;22(3):156-61. doi: 10.1016/j.suronc.2013.04.002. Epub 2013 May 20. Review.

17.

"The air got to it:" exploring a belief about surgery for lung cancer.

DeLisser HM, Keirns CC, Clinton EA, Margolis ML.

J Natl Med Assoc. 2009 Aug;101(8):765-71. Review.

PMID:
19715038
18.

Radiogenomics predicting tumor responses to radiotherapy in lung cancer.

Das AK, Bell MH, Nirodi CS, Story MD, Minna JD.

Semin Radiat Oncol. 2010 Jul;20(3):149-55. doi: 10.1016/j.semradonc.2010.01.002. Review.

19.

Commercially available prognostic molecular models in early-stage lung cancer: a review of the Pervenio Lung RS and Myriad myPlan Lung Cancer tests.

Zheng Y, Bueno R.

Expert Rev Mol Diagn. 2015 May;15(5):589-96. doi: 10.1586/14737159.2015.1028371. Review.

PMID:
25896578
20.

[Lung cancer: progress in diagnosis and treatments. Topics: II. Diagnosis and examination; 3. Pathological diagnosis, molecular testing and biomarkers].

Kondo C, Yatabe Y.

Nihon Naika Gakkai Zasshi. 2014 Jun 10;103(6):1281-6. Review. Japanese. No abstract available.

PMID:
25151791
Items per page

Supplemental Content

Write to the Help Desk